Analystreport

Intercept Pharmaceuticals Inc (NASDAQ: ICPT) had its price target raised by analysts at UBS Group AG to $139.00. They now have a "buy" rating on the stock.

Intercept Pharmaceuticals, Inc.  (ICPT) 
Last intercept pharmaceuticals, inc. earnings: 2/25 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.interceptpharma.com/investor-relations